<DOC>
	<DOCNO>NCT01903863</DOCNO>
	<brief_summary>The purpose study assess impact schedule fresh frozen plasma ( FFP ) administration extracorporeal membrane oxygenation ( ECMO ) pump longevity critically ill pediatric neonatal patient . Almost ECMO patient receive multiple FFP transfusion ECMO course . The investigator propose schedule FFP may maintain pro anticoagulation balance thus mitigate need expensive dangerous ECMO pump change . In addition , may lead less overall transfusion product ( red blood cell , platelet , FFP ) coagulation homeostasis maintain . The subject neonatal pediatric patient require ECMO support reason pediatric pediatric cardiac critical care unit . Subjects randomize receive every day FFP infusion FFP administration per current standard care . ECMO pump longevity ( hour ) FFP use compare two group There small risk study subject may receive FFP transfusion therefore increase associated risk however also possible subject may benefit less ECMO circuit change and/or few transfusion blood product .</brief_summary>
	<brief_title>The Effect Prophylactic FFP Administration ECMO Circuit Longevity</brief_title>
	<detailed_description />
	<criteria>All patient &lt; 18 year receive ECMO 1 . Planned withdrawal life sustain therapy next 48 hour 2 . Previous enrollment study 3 . Patients consent within 48 hour 4 . Pregnant patient</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>FFP</keyword>
	<keyword>fresh frozen plasma</keyword>
	<keyword>ECMO</keyword>
	<keyword>extracorporeal membrane oxygenation</keyword>
	<keyword>anticoagulation</keyword>
	<keyword>transfusion</keyword>
</DOC>